Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOcado Regulatory News (OCDO)

Share Price Information for Ocado (OCDO)

Share Price is delayed by 15 minutes
Get Live Data
199.90    -9.30 (-4.45%)
Bid:
202.20
Ask:
202.40
Spread: 0.20 (0.099%)
Market Cap: £1.66b
OCDO Live PriceLast checked at - London Stock Exchange

Intraday Ocado Share Chart

Statement regarding AutoStore

11 Mar 2022 08:01

RNS Number : 4880E
Ocado Group PLC
11 March 2022
Β 

OCADO GROUP PLC

11 March 2022

Β 

Ocado Group plc

ITC investigation over: conclusive victory for Ocado

ITC confirms all AutoStore cavity bot patents are invalid

On 10th March, the International Trade Commission, consisting of 5 experienced patent judges, decided in favour of Ocado on all points. Every patent AutoStore asserted in its ITC complaint was found either invalid or not infringed by Ocado's proprietary state of the art technology.

All of the 33 claims that originally constituted AutoStore's complaint to the ITC have now been rejected for a second time, or abandoned by AutoStore. AutoStore's key cavity bot patents, the UK versions of which are the only patents being asserted against Ocado in the High Court case starting next week, were all found to be invalid. A fourth, unrelated, patent was held not to be infringed.

Unusually, the ITC accepted review of the judge's original decision and in the same notice gave its decision on the merits, which further emphasises the strength of these findings.

Ocado continues actively to pursue its claims against AutoStore for infringement of Ocado's IP rights in both the United States and Europe, including its antitrust "Walker Process" claim against AutoStore in East Virginia and its infringement of five Ocado patents in New Hampshire. Ocado anticipates court determinations injuncting AutoStore and awarding Ocado damages for AutoStore's infringement of Ocado's patents.

An Ocado spokesperson said:

"We welcome the ITC's decision, which comprehensively confirms the judge's original findings last December. All 33 of the patent claims asserted against Ocado have now been confirmed for a second time to be either invalid or not infringed, demonstrating again how misguided AutoStore's complaint has been. The ITC investigation is now at its end.

Β 

We expect further vindication in the High Court in London in the weeks ahead, where AutoStore has already abandoned half of the patents in the case."

Β 

Contacts

● David Shriver, Director of Communications, Ocado Group plc, on 01707 228 000

● Martin Robinson at Tulchan Communications on 020 7353 4200

Β 

Β 

Β 

Person responsible for arranging the release of this announcement:

Β 

Neill Abrams

Group General Counsel & Company Secretary

Ocado Group plc

Buildings One & Two

Trident Place

Mosquito Way

Hatfield

Hertfordshire AL10 9UL

Fax: +44 (0)1707 227 997

email: company.secretary@ocado.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
STRFIFEDVAILLIF
Date   Source Headline
25th Nov 20208:35 amRNSDirectorate Change
18th Nov 20205:50 pmRNSDirector/PDMR Shareholding
9th Nov 20205:14 pmRNSDirector/PDMR Shareholding
2nd Nov 20203:20 pmRNSTotal Voting Rights
2nd Nov 20207:00 amRNSStatement regarding acquisitions
2nd Nov 20207:00 amRNSTrading Statement
16th Oct 20205:20 pmRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSTotal Voting Rights
1st Oct 20201:27 pmRNSStatement regarding Autostore
24th Sep 20209:22 amRNSDirector/PDMR Shareholding
18th Sep 20208:16 amRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSTrading Statement
8th Sep 20207:00 amRNSDirectorate Change
1st Sep 20206:22 pmRNSTotal Voting Rights
27th Aug 20207:00 amRNSDirectorate Change
20th Aug 20205:45 pmRNSDirector/PDMR Shareholding
3rd Aug 20204:54 pmRNSTotal Voting Rights
28th Jul 20208:42 amRNSBlock listing Interim Review
24th Jul 20204:40 pmRNSSecond Price Monitoring Extn
24th Jul 20204:35 pmRNSPrice Monitoring Extension
16th Jul 20205:41 pmRNSDirector/PDMR Shareholding
15th Jul 20207:00 amRNSReplacement - Half-year Report
14th Jul 20207:00 amRNSHalf-year Report
1st Jul 20206:26 pmRNSDirector/PDMR Shareholding
1st Jul 20205:09 pmRNSTotal Voting Rights
17th Jun 20205:11 pmRNSDirector/PDMR Shareholding
15th Jun 20205:07 pmRNSHolding(s) in Company
12th Jun 202010:56 amRNSHolding(s) in Company
11th Jun 20207:00 amRNSResults of Capital Raise
10th Jun 20205:23 pmRNSRetail Offer
10th Jun 20205:12 pmRNSProposed Placing of Shares and Convertible Bond
1st Jun 20205:10 pmRNSTotal Voting Rights
28th May 20204:55 pmRNSDirector/PDMR Shareholding
28th May 202012:45 pmRNSAdditional Listing
21st May 202012:55 pmRNSDirector/PDMR Shareholding
6th May 20205:50 pmRNSDisclosure of rights attached to listed securities
6th May 20205:43 pmRNSResult of AGM
6th May 20207:00 amRNSTrading Statement
5th May 202012:49 pmRNSTotal Voting Rights
29th Apr 202012:17 pmRNSDisclosure of rights attached to listed securities
28th Apr 20207:00 amRNSStatement regarding AGM Trading Statement
20th Apr 20209:07 amRNSDirector/PDMR Shareholding
20th Apr 20207:00 amRNSAGM Statement
16th Apr 20205:00 pmRNSHolding(s) in Company
1st Apr 202012:29 pmRNSTotal Voting Rights
26th Mar 20206:28 pmRNSDirector/PDMR Shareholding
25th Mar 20209:51 amRNSDirector/PDMR Shareholding
24th Mar 20205:42 pmRNSDirector/PDMR Shareholding
24th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20204:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.